Operating Income (Loss) in USD of LEXICON PHARMACEUTICALS, INC. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
LEXICON PHARMACEUTICALS, INC. quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q3 2025.
  • LEXICON PHARMACEUTICALS, INC. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$12.2M, a 80.9% increase year-over-year.
  • LEXICON PHARMACEUTICALS, INC. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$66.9M, a 68.3% increase year-over-year.
  • LEXICON PHARMACEUTICALS, INC. annual Operating Income (Loss) for 2024 was -$197M, a 14.8% decline from 2023.
  • LEXICON PHARMACEUTICALS, INC. annual Operating Income (Loss) for 2023 was -$172M, a 70.5% decline from 2022.
  • LEXICON PHARMACEUTICALS, INC. annual Operating Income (Loss) for 2022 was -$101M, a 15.7% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

LEXICON PHARMACEUTICALS, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$66.9M -$12.2M +$51.5M +80.9% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 -$118M $3.74M +$59.1M 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 -$177M -$25.7M +$19.7M +43.4% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 -$197M -$32.7M +$14M +30% 01 Oct 2024 31 Dec 2024 10-K 07 Mar 2025
Q3 2024 -$211M -$63.7M -$14.1M -28.3% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 -$197M -$55.4M -$11.1M -25.1% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025
Q1 2024 -$186M -$45.3M -$14.2M -45.6% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 -$172M -$46.7M -$16.5M -54.4% 01 Oct 2023 31 Dec 2023 10-K 07 Mar 2025
Q3 2023 -$155M -$49.6M -$26.5M -115% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 -$129M -$44.2M -$20.2M -84.3% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024
Q1 2023 -$109M -$31.1M -$7.76M -33.2% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024
Q4 2022 -$101M -$30.3M -$4.95M -19.5% 01 Oct 2022 31 Dec 2022 10-K 07 Mar 2025
Q3 2022 -$95.8M -$23.1M -$133K -0.58% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023
Q2 2022 -$95.7M -$24M -$6.05M -33.7% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023
Q1 2022 -$89.6M -$23.4M -$2.54M -12.2% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 -$87.1M -$25.3M -$17.9M -240% 01 Oct 2021 31 Dec 2021 10-K 25 Mar 2024
Q3 2021 -$69.2M -$23M -$110M -126% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $40.4M -$18M +$46.6M +72.2% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 -$6.2M -$20.8M +$41.6M +66.6% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 -$47.8M -$7.46M +$39.8M +84.2% 01 Oct 2020 31 Dec 2020 10-K 03 Mar 2023
Q3 2020 -$87.6M $86.7M -$138M -61.4% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 $50.4M -$64.6M -$46M -248% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q1 2020 $96.5M -$62.4M -$45M -257% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 $141M -$47.2M -$34.9M -282% 01 Oct 2019 31 Dec 2019 10-K 12 Mar 2020
Q3 2019 $176M $225M +$248M 01 Jul 2019 30 Sep 2019 10-Q 30 Oct 2020
Q2 2019 -$71.3M -$18.5M +$11.7M +38.7% 01 Apr 2019 30 Jun 2019 10-Q 29 Jul 2020
Q1 2019 -$83M -$17.5M +$20.2M +53.7% 01 Jan 2019 31 Mar 2019 10-Q 27 Apr 2020
Q4 2018 -$103M -$12.4M +$16.6M +57.4% 01 Oct 2018 31 Dec 2018 10-K 12 Mar 2020
Q3 2018 -$120M -$22.9M +$5.68M +19.9% 01 Jul 2018 30 Sep 2018 10-K 12 Mar 2020
Q2 2018 -$126M -$30.3M +$3.22M +9.61% 01 Apr 2018 30 Jun 2018 10-K 12 Mar 2020
Q1 2018 -$129M -$37.7M +$1.8M +4.55% 01 Jan 2018 31 Mar 2018 10-K 12 Mar 2020
Q4 2017 -$131M -$29M +$2.31M +7.39% 01 Oct 2017 31 Dec 2017 10-K 15 Mar 2019
Q3 2017 -$133M -$28.6M +$6.33M +18.1% 01 Jul 2017 30 Sep 2017 10-K 15 Mar 2019
Q2 2017 -$139M -$33.5M +$3.53M +9.54% 01 Apr 2017 30 Jun 2017 10-K 15 Mar 2019
Q1 2017 -$143M -$39.5M -$5.64M -16.7% 01 Jan 2017 31 Mar 2017 10-K 15 Mar 2019
Q4 2016 -$137M -$31.3M -$120M -135% 01 Oct 2016 31 Dec 2016 10-K 01 Mar 2018
Q3 2016 -$17.5M -$34.9M -$1.26M -3.73% 01 Jul 2016 30 Sep 2016 10-K 01 Mar 2018
Q2 2016 -$16.2M -$37M -$10.3M -38.7% 01 Apr 2016 30 Jun 2016 10-K 01 Mar 2018
Q1 2016 -$5.88M -$33.9M -$7.34M -27.7% 01 Jan 2016 31 Mar 2016 10-K 01 Mar 2018
Q4 2015 $1.47M $88.4M +$91.8M 01 Oct 2015 31 Dec 2015 10-K 06 Mar 2017
Q3 2015 -$90.3M -$33.7M +$6.66M +16.5% 01 Jul 2015 30 Sep 2015 10-K 06 Mar 2017
Q2 2015 -$97M -$26.7M -$577K -2.21% 01 Apr 2015 30 Jun 2015 10-K 06 Mar 2017
Q1 2015 -$96.4M -$26.5M +$3.95M +12.9% 01 Jan 2015 31 Mar 2015 10-K 06 Mar 2017
Q4 2014 -$100M -$3.45M +$13.5M +79.7% 01 Oct 2014 31 Dec 2014 10-K 11 Mar 2016
Q3 2014 -$114M -$40.3M -$9.12M -29.2% 01 Jul 2014 30 Sep 2014 10-K 11 Mar 2016
Q2 2014 -$105M -$26.1M +$2.51M +8.78% 01 Apr 2014 30 Jun 2014 10-K 11 Mar 2016
Q1 2014 -$107M -$30.5M -$4.92M -19.2% 01 Jan 2014 31 Mar 2014 10-K 11 Mar 2016
Q4 2013 -$102M -$17M +$7.52M +30.7% 01 Oct 2013 31 Dec 2013 10-K 12 Mar 2015
Q3 2013 -$110M -$31.2M -$2.16M -7.42% 01 Jul 2013 30 Sep 2013 10-K 12 Mar 2015
Q2 2013 -$108M -$28.6M -$3.14M -12.3% 01 Apr 2013 30 Jun 2013 10-K 12 Mar 2015
Q1 2013 -$105M -$25.6M +$3.83M +13% 01 Jan 2013 31 Mar 2013 10-K 12 Mar 2015
Q4 2012 -$108M -$24.5M +$8.85M +26.5% 01 Oct 2012 31 Dec 2012 10-K 07 Mar 2014
Q3 2012 -$117M -$29.1M -$3.37M -13.1% 01 Jul 2012 30 Sep 2012 10-K 07 Mar 2014
Q2 2012 -$114M -$25.5M +$446K +1.72% 01 Apr 2012 30 Jun 2012 10-K 07 Mar 2014
Q1 2012 -$114M -$29.4M -$247K -0.85% 01 Jan 2012 31 Mar 2012 10-K 07 Mar 2014
Q4 2011 -$114M -$33.3M 01 Oct 2011 31 Dec 2011 10-K 11 Mar 2013
Q3 2011 -$25.7M -$1.44M -5.93% 01 Jul 2011 30 Sep 2011 10-K 11 Mar 2013
Q2 2011 -$25.9M -$1.85M -7.69% 01 Apr 2011 30 Jun 2011 10-K 11 Mar 2013
Q1 2011 -$29.1M 01 Jan 2011 31 Mar 2011 10-K 11 Mar 2013
Q3 2010 -$24.3M 01 Jul 2010 30 Sep 2010 10-Q 01 Nov 2011
Q2 2010 -$24.1M 01 Apr 2010 30 Jun 2010 10-Q 09 Aug 2011

LEXICON PHARMACEUTICALS, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$197M -$25.4M -14.8% 01 Jan 2024 31 Dec 2024 10-K 07 Mar 2025
2023 -$172M -$71M -70.5% 01 Jan 2023 31 Dec 2023 10-K 07 Mar 2025
2022 -$101M -$13.7M -15.7% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2025
2021 -$87.1M -$39.3M -82.2% 01 Jan 2021 31 Dec 2021 10-K 25 Mar 2024
2020 -$47.8M -$189M -134% 01 Jan 2020 31 Dec 2020 10-K 03 Mar 2023
2019 $141M +$245M 01 Jan 2019 31 Dec 2019 10-K 10 Mar 2022
2018 -$103M +$27.3M +20.9% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2021
2017 -$131M -$3.45M -2.72% 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020
2016 -$127M -$129M -8763% 01 Jan 2016 31 Dec 2016 10-K 15 Mar 2019
2015 $1.47M +$102M 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018
2014 -$100M +$2.01M +1.96% 01 Jan 2014 31 Dec 2014 10-K 06 Mar 2017
2013 -$102M +$6.04M +5.58% 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2016
2012 -$108M +$5.68M +4.98% 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2015
2011 -$114M -$18.4M -19.2% 01 Jan 2011 31 Dec 2011 10-K 07 Mar 2014
2010 -$95.7M 01 Jan 2010 31 Dec 2010 10-K 11 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.